Affiliation:
1. Aswan University
2. South Valley University
Abstract
Abstract
Background: Alopecia areata (AA) is considered to be an autoimmune disease that has different treatment modalities. Topical vitamin D analog and PRP are recognized as effective therapies for AA. The aim of the study was a compare the effect of topical vitamin D analog (calcipotriol), intra-lesion PRP, and a combination of both on AA patients.
Patients and methods:
In this double-blinded randomized clinical trial study, a total of 39 cases (patients with AA) were divided into 3 groups: Group I (n = 13): cases received topical Vit D3 analog (calcipotriol) 0.005% twice daily for 3 months with follow up. Group II (n = 13): cases received PRP intra-lesion injection for 6 consecutive sessions 2 weeks apart. Combined Group III (n = 13):cases received both treatments. Clinical evaluation by SALT score (severity alopecia tool) and dermoscopic examination were performed before and after treatment. Study registration at clinicaltrial.com was done, approval number: NCT05954104. Date of registration: 23/6/2023.
Results:
In this study, there was a significant decrease in the mean SALT score for the three groups (p<0.001). The absolute reduction in G-I (calcipotriol) was 3.73 points, in G-II (PRP), was 6.87 points, and in G-III(combined) was 18.98 points This reduction was significant (p<0.001) more evident in G-III followed by G-II and then G-I. There was a significant reduction in Dermoscopic findings after treatment in the three groups.
Conclusion:
Significant reductions in SALT levels were observed across all three groups, with the combination of calcipotriol and PRP being particularly noteworthy. Significant reductions in dermoscopic symptoms were observed following treatment.
Publisher
Research Square Platform LLC
Reference30 articles.
1. Alopecia areata;Pratt CH;Nature Reviews Disease Primers,2017
2. Circulating adiponectin and visfatin levels in rheumatoid arthritis and their correlation with disease activity: A meta-analysis;Lee YH;International journal of rheumatic diseases,2018
3. Alopecia areata: an update on etiopathogenesis, diagnosis, and management;Zhou C;Clinical Reviews in Allergy & Immunology,2021
4. The role of lymphocytes in the development and treatment of alopecia areata;Guo H;Expert review of clinical immunology,2015
5. Alopecia areata: Part 1: pathogenesis, diagnosis, and prognosis;Spano F;Canadian Family Physician,2015